Search
for
Sort by
Research 481–510 of 1000+
- Characteristics of telogen effluvium in COVID-19 in western Iran (2020)
- Telogen effluvium, Beau lines, and acral peeling associated with COVID-19 infection
- Race, ethnicity, and comorbidities are critical factors in the diagnosis of telogen effluvium during the COVID-19 pandemic
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- COVID-19: A catalyst for innovative hybrid teledermatology workflows to increase access and improve patient care at a large group practice
- Correlation Between Interest in COVID-19 Hair Loss and COVID-19 Surges: Analysis of Google Trends
- COVID-19 Infection Induce miR-371a-3p Upregulation Resulting in Influence on Male Fertility
- Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
- Androgenetic alopecia in COVID-19: Compared to what?
- Association Between Hair Diseases and COVID-19 Pandemic-Related Stress: A Cross-Sectional Study Analysis
- COVID‐19, androgens, and androgenic alopecia
- COVID-19 lockdown and beyond: Home practice solutions for developing microsurgical skills.
- The role of autologous micrografts injection from the scalp tissue in the treatment of COVID‐19 associated telogen effluvium: Clinical and trichoscopic evaluation
- Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID‐19 telogen effluvium?
- Clinical, laboratory and psychological aspects of moderate COVID-19 in cardiovascular patients one month after discharge from the hospital
- Alopecia and severity of COVID-19: a cross-sectional study in Peru
- Comment on “Androgenetic alopecia present in the majority of patients hospitalized with COVID-19”
- Cepharanthine: A review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Impact of anti-androgen therapies on COVID-19 susceptibility: a case-control study in male population from two COVID-19 regional centers of Lombardy (Italy)
- Skin Diseases Associated With COVID-19: A Narrative Review
- Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies
- Diagnosis of stress-associated dermatologic conditions in New York City safety-net hospitals during the COVID-19 pandemic
- Ultrastructural evidence for anagen hair follicle infection with SARS‐CoV‐2 in early‐onset COVID‐19 effluvium
- Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium
- Androgenetic alopecia and COVID‐19: Is there a clinical connection?
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- Indirect skin sign of COVID‐19 days: Striae rubrae
- COVID-19 patients at referral to hospital during the first peak of disease: Common clinical findings including myalgia and fatigue
- Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia